Ampyra Prices, Coupons, Copay Cards & Patient Assistance
Ampyra (dalfampridine) is a member of the miscellaneous central nervous system agents drug class and is commonly used for Multiple Sclerosis.
A generic version of Ampyra is available. See dalfampridine prices.
Ampyra prices
Oral Tablet, Extended Release
10 mg Ampyra oral tablet, extended release from $4,373.96 for 60 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 60 | $72.90 | $4,373.96 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Ampyra Coupons, Copay Cards and Rebates
Ampyra offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Ampyra Co-Pay Program
Eligible commercially insured patients may pay as little as $10 per monthly prescription with a savings up to $1000 per fill; annual maximum savings of $12,000.
- Applies to:
- Ampyra
- Number of uses:
- per prescription per year
Form more information phone: 888-881-1918 or Visit website
Ampyra Free Trial Program
Eligible patients may receive a 60-day FREE trial prescription; patients who have received a prescription within the last 12 months are not eligible; for additional information contact the program at 888-881-1918.
- Applies to:
- Ampyra
- Number of uses:
- One-time offer
Form more information phone: 888-881-1918
Patient Assistance & Copay Programs for Ampyra
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Rx Outreach Medications
Eligibility requirements:- May have insurance
- Determined case by case
- Not required
- The patient must also be residing in the US.
- Some medications are available for a fee of $20 for up to a 180 day supply. Check the Rx Outreach website for the exact price and most current medication list. Contact Program for Spanish Application(s)/Form(s).
- Ampyra (dalfampridine) Tablet; Extended-Release
More information please phone: 314-222-0472 Visit website
Provider: HealthWell Foundation Copay Program
Eligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
- Ampyra (dalfampridine) Tablet; Extended-Release
More information please phone: 800-675-8416 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Ampyra (dalfampridine)
- Check interactions
- Compare alternatives
- Reviews (77)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- Breastfeeding
- En español